Analysis and standardization of the new anxiolytic drug afobazole

By Milkina S.   Stepanenko O.   Grushevskaya L.   Avdyunina N.   Pyatin B.   Bagirova V.   Nechaeva E.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 7, 2006-07 ,pp. : 405-406

Springer Publishing Company

Access to resources Recommend Favorite

Analysis and Standardization of the New Psychotropic and Immunotropic Drug Ladasten

By Karavanova D. E.   Pyatin B. M.   Klimova N. V.   Avdyunina N. I.   Stepanenko O. B.   Tsvetkova E. A.   Shamenkova N. V.   Prokof'eva V. I.  

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 10, 2003-10 ,pp. : 543-546

Springer Publishing Company

Access to resources Recommend Favorite

Study of Physicochemical Properties and Development of Pharmaceutial Analysis of the New Antiarrhythmic Class III Drug Cardiocyclide

By Grushevskaya L. N.   Avdyunina N. I.   Stepanenko O. B.   Pyatin B. M.   Prokof'eva V. I.   Lezina V. P.  

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 12, 2003-12 ,pp. : 677-680

Springer Publishing Company

Access to resources Recommend Favorite

New approaches for identifying antiarrhythmic drug targets

By Gilmour Jr Robert F  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 1, 2004-02 ,pp. : 1-5

Informa Healthcare

Access to resources Recommend Favorite

Qualitative and Quantitative Determination of the New Antiarrhythmic Drug Ritmidazole

By Stepanov A. V.   Smirnova L. A.   Spasov A. A.  

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 8, 2003-08 ,pp. : 440-443

Springer Publishing Company

Access to resources Recommend Favorite